Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo could replace ibuprofen for Post-Surgery pain

NCT ID NCT07620665

Symptom relief Sponsor: Gangnam Severance Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two pain relief combinations after minimally invasive gallbladder removal: opiranserin plus acetaminophen versus ibuprofen plus acetaminophen. 88 adults will be randomly assigned to one of the two groups. The goal is to see if the new combination controls pain just as well as the standard one.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
opiranserin plus acetaminophen
What this could lead to
If it works, this could offer a new pain relief option after gallbladder surgery that avoids NSAIDs.
What could go wrong
This is a small, early-stage trial with only 88 people, so results may not apply to everyone. It is designed to show non-inferiority, not superiority, so it may not prove opiranserin is better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 88 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patient undergoing minimally invasive cholecystectomy Exclusion Criteria: * Known hypersensitivity or allergy to acetaminophen, NSAIDs, opiranserin, or fentanyl. * pre-existing chronic pain, * clinically significant ECG findings (QRS \> 200 msec, QTcF \>450 msec) * severe renal impairment * severe hepatic impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cholecystectomy, laparoscopic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cholecystectomy, laparoscopic Cholecystectomy, robotic Minimally invasive cholecystectomy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gangnam Severance Hospital

    NOT_YET_RECRUITING

    Seoul, 06273, South Korea

  • Gangnam Severance Hospital

    RECRUITING

    Seoul, 06273, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.